Expansion of the GRIA2 phenotypic representation: a novel de novo loss of function mutation in a case with childhood onset schizophrenia

被引:0
|
作者
Anna Alkelai
Shahar Shohat
Lior Greenbaum
Tanya Schechter
Benjamin Draiman
Eti Chitrit-Raveh
Shlomit Rienstein
Neha Dagaonkar
Daniel Hughes
Vimla S. Aggarwal
Erin L. Heinzen
Sagiv Shifman
David B. Goldstein
Yoav Kohn
机构
[1] Columbia University Medical Center,Institute for Genomic Medicine
[2] The Hebrew University of Jerusalem,Department of Genetics, The Institute of Life Sciences
[3] Sheba Medical Center,The Danek Gertner Institute of Human Genetics
[4] Sheba Medical Center,The Joseph Sagol Neuroscience Center
[5] Tal Aviv University,Sackler Faculty of Medicine
[6] Jerusalem Mental Health Center,Department of Child and Adolescent Psychiatry
[7] Eitanim Psychiatric Hospital,Eshelman School of Pharmacy
[8] University of North Carolina,undefined
[9] Hadassah-Hebrew University School of Medicine,undefined
来源
Journal of Human Genetics | 2021年 / 66卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Childhood-onset schizophrenia (COS) is a rare form of schizophrenia with an onset before 13 years of age. There is rising evidence that genetic factors play a major role in COS etiology, yet, only a few single gene mutations have been discovered. Here we present a diagnostic whole-exome sequencing (WES) in an Israeli Jewish female with COS and additional neuropsychiatric conditions such as obsessive-compulsive disorder (OCD), anxiety, and aggressive behavior. Variant analysis revealed a de novo novel stop gained variant in GRIA2 gene (NM_000826.4: c.1522 G > T (p.Glu508Ter)). GRIA2 encodes for a subunit of the AMPA sensitive glutamate receptor (GluA2) that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. GluA2 subunit mutations are known to cause variable neurodevelopmental phenotypes including intellectual disability, autism spectrum disorder, epilepsy, and OCD. Our findings support the potential diagnostic role of WES in COS, identify GRIA2 as possible cause to a broad psychiatric phenotype that includes COS as a major manifestation and expand the previously reported GRIA2 loss of function phenotypes.
引用
收藏
页码:339 / 343
页数:4
相关论文
共 50 条
  • [31] A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer
    Diez, Orland
    Gutierrez-Enriquez, Sara
    Mediano, Carmen
    Masas, Miriam
    Saura, Cristina
    Gadea, Neus
    Balmana, Judith
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) : 221 - 225
  • [32] A case of a childhood onset developmental encephalopathy with a novel de novo truncating variant in the Membrane Protein Palmitoylated 5 (MPP5) gene
    Zanotta, Nicoletta
    Panzeri, Elena
    Minghetti, Sara
    Citterio, Andrea
    Giorda, Roberto
    Marelli, Susan
    Bassi, Maria Teresa
    Zucca, Claudio
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 116 : 151 - 155
  • [33] Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene
    Sugie, Kazuma
    Yoshizawa, Hiroyuki
    Onoue, Kenji
    Nakanishi, Yoko
    Eura, Nobuyuki
    Ogawa, Megumu
    Nakano, Tomoya
    Sakaguchi, Yasuhiro
    Hayashi, Yukiko K.
    Kishimoto, Toshifumi
    Shima, Midori
    Saito, Yoshihiko
    Nishino, Ichizo
    Ueno, Satoshi
    NEUROPATHOLOGY, 2016, 36 (06) : 561 - 565
  • [34] A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer
    Orland Diez
    Sara Gutiérrez-Enríquez
    Carmen Mediano
    Miriam Masas
    Cristina Saura
    Neus Gadea
    Judith Balmaña
    Breast Cancer Research and Treatment, 2010, 121 : 221 - 225
  • [35] Andersen-Tawil syndrome (ATS): Novel de novo mutation in the KCNJ2 gene - a case report
    Prochnicki, A.
    Tettenborn, B.
    Felbecker, A.
    SWISS MEDICAL WEEKLY, 2016, 146 : 117S - 117S
  • [36] A De novo Loss-of-Function Mutation in PAFAH1B1 Identified in a Single Case with Agyria-Pachygyria Complex
    Ou, Yali
    Xiang, Bingwu
    Yang, Liu
    Chen, Wei
    Chen, Xiang
    Cai, Tao
    JOURNAL OF PEDIATRIC NEUROLOGY, 2020, 18 (01) : 33 - 38
  • [37] De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene
    Chemin, Jean
    Siquier-Pernet, Karine
    Nicouleau, Michaeel
    Barcia, Giulia
    Ahmad, Ali
    Medina-Cano, Daniel
    Hanein, Sylvain
    Altin, Nami
    Hubert, Laurence
    Bole-Feysot, Christine
    Fourage, Cecile
    Nitschke, Patrick
    Thevenon, Julien
    Rio, Marlene
    Blanc, Pierre
    Vidal, Celine
    Bahi-Buisson, Nadia
    Desguerre, Isabelle
    Munnich, Arnold
    Lyonnet, Stanislas
    Boddaert, Nathalie
    Fassi, Emily
    Shinawi, Marwan
    Zimmerman, Holly
    Amiel, Jeanne
    Faivre, Laurence
    Colleaux, Laurence
    Lory, Philippe
    Cantagrel, Vincent
    BRAIN, 2018, 141 : 1998 - 2013
  • [38] Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients
    Wang, Xu
    Cui, Di
    Ding, Changhong
    Chen, Chunhong
    Wang, Xiaohui
    Fang, Fang
    Jin, Hong
    Ren, Xiaotun
    GENES, 2022, 13 (05)
  • [39] A novel de novo truncating TRIM8 variant associated with childhood-onset focal segmental glomerulosclerosis without epileptic encephalopathy: a case report
    Yoko Shirai
    Kenichiro Miura
    Naoto Kaneko
    Kiyonobu Ishizuka
    Amane Endo
    Taeko Hashimoto
    Shoichiro Kanda
    Yutaka Harita
    Motoshi Hattori
    BMC Nephrology, 22
  • [40] A novel de novo truncating TRIM8 variant associated with childhood-onset focal segmental glomerulosclerosis without epileptic encephalopathy: a case report
    Shirai, Yoko
    Miura, Kenichiro
    Kaneko, Naoto
    Ishizuka, Kiyonobu
    Endo, Amane
    Hashimoto, Taeko
    Kanda, Shoichiro
    Harita, Yutaka
    Hattori, Motoshi
    BMC NEPHROLOGY, 2021, 22 (01)